ImmunityBio
- Market cap
- 10.33B
- P/E (TTM)i
- -10.26
- P/Bi
- -9.87
- EPSi
- -0.38
- Div yieldi
- 0.00%
- 52W posi
- 74%
Anonymous reader poll. Unscientific, not investment advice.
ImmunityBio last traded at 9.75, up 0.62% on the session. At current prices, the business is worth about 10.33B, the #1397 most valuable US-listed company we track. Across 3 analysts the consensus rating is Buy, with an average price target of 13.00 (+33%). Over the past year the stock has ranged from 1.95 to 12.43; it now sits 74% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 1% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Its last 3 Buy calls have averaged close to flat (+2%) three months out - no strong edge on this name specifically.
- Recent price momentum is +150.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 11.8% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 9.69
- Open
- 9.50
- Day range
- 9.33 - 9.93
- Avg price
- 9.72
- Volume
- 11.78M
- Turnover
- 114.52M
- Turnover ratei
- 2.90%
- Volume ratioi
- 0.56
- Amplitudei
- 6.19%
- 52-week rangei
- 1.95 - 12.43
Valuation
- P/Ei
- -25.66
- P/E (TTM)i
- -10.26
- P/Bi
- -9.87
- EPSi
- -0.38
- Book value / shi
- -0.99
- Net profit
- -402.74M
- Net assets
- -1.05B
Share structure
- Market cap
- 10.33B
- Float capi
- 3.97B
- Shares out
- 1.06B
- Float sharesi
- 406.69M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
21.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-20.94M net over the window
Short interest
- Shares short
- 125.41M
- % of floati
- 11.83%
- Days to coveri
- 15.86
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of ImmunityBio (IBRX)?
ImmunityBio last traded at 9.75. The quote on this page refreshes every few seconds while US markets are open.
What is ImmunityBio's market cap?
About 10.33B.
What is the P/E ratio of ImmunityBio?
The trailing twelve-month P/E is -10.26. The Valuation tab shows it against the stock's own five-year range.
Does ImmunityBio pay a dividend?
ImmunityBio does not currently pay a regular dividend.
Is ImmunityBio a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 13.00, which implies 33.3% upside from the current price. This is not investment advice.
What is ImmunityBio's StockVane Quant Rating?
The StockVane Momentum strategy currently rates ImmunityBio a B (Buy). Twelve-month momentum in the top 1% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 07:37:04 · For reference only, not investment advice and not tailored to your situation.